Genetically manipulated bacterial toxin as a new generation mucosal adjuvant - PubMed (original) (raw)

Review

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant

M Yamamoto et al. Scand J Immunol. 2001 Mar.

Free article

Abstract

Cholera toxin (CT) and heat-labile toxin (LT) of Escherichia coli act as adjuvants for the enhancement of mucosal and serum antibody (Ab) responses to mucosally co-administered protein antigen (Ag). Both LT and CT induce B7-2 expression on antigen-presenting cells (APCs) for subsequent co-stimulatory signalling to CD4+ T cells. CT directly affects CD4+ T cells activated via the TCR-CD3 complex with selective inhibition of Th1 responses whereas LT maintains Th1 cytokine responses with inhibition of interleukin (IL)-4 production. Interestingly, while CT failed to induce mucosal adjuvant activity in the absence of IL-4, LT did so. Nontoxic mutant (m)CTs (S61F and E112K) retain adjuvant properties by inducing CD4+ Th2 cells, which provided effective help for the Ag-specific mucosal immunoglobulin (Ig)A, as well as serum IgG1, IgE and IgA Ab responses. The mCT E112K has been shown to exhibit two distinct mechanisms for its adjuvanticity. Firstly, mCT enhanced the B7-2 expression of APCs. Secondly, this nontoxic CT derivative directly affected CD4+ T cells and selectively inhibited Th1 cytokine responses. Thus, several lines of evidence indicate that enzyme activity can be separated from adjuvant properties of CT and this offers promise for the development of safe delivery of vaccines for mucosal IgA responses.

PubMed Disclaimer

Cited by

Enterotoxigenic Escherichia coli heat-stable toxin and heat-labile toxin toxoid fusion 3xSTaN12S-dmLT induces neutralizing anti-STa antibodies in subcutaneously immunized mice.
Nandre R, Ruan X, Duan Q, Zhang W. Nandre R, et al. FEMS Microbiol Lett. 2016 Nov 1;363(21):fnw246. doi: 10.1093/femsle/fnw246. FEMS Microbiol Lett. 2016. PMID: 27810884 Free PMC article.
M cell-targeted mucosal vaccine strategies.
Yamamoto M, Pascual DW, Kiyono H. Yamamoto M, et al. Curr Top Microbiol Immunol. 2012;354:39-52. doi: 10.1007/82_2011_134. Curr Top Microbiol Immunol. 2012. PMID: 21688209 Free PMC article. Review.
Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
Connell TD. Connell TD. Expert Rev Vaccines. 2007 Oct;6(5):821-34. doi: 10.1586/14760584.6.5.821. Expert Rev Vaccines. 2007. PMID: 17931161 Free PMC article. Review.
Mucosal and systemic adjuvant activity of alphavirus replicon particles.
Thompson JM, Whitmore AC, Konopka JL, Collier ML, Richmond EM, Davis NL, Staats HF, Johnston RE. Thompson JM, et al. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3722-7. doi: 10.1073/pnas.0600287103. Epub 2006 Feb 27. Proc Natl Acad Sci U S A. 2006. PMID: 16505353 Free PMC article.

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant - PubMed (original) (raw)